VEPEMB in elderly Hodgkin’s lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Peterson, 1982, Effect of age on therapeutic response and survival in advanced Hodgkin’s disease, Cancer Treat Rep, 66, 889
Wedelin, 1984, Prognostic factors in Hodgkin’s disease with special reference to age, Cancer, 53, 1202, 10.1002/1097-0142(19840301)53:5<1202::AID-CNCR2820530530>3.0.CO;2-L
Eghbali, 1984, Hodgkin’s disease in the elderly. A series of 30 patients aged older than 70 years, Cancer, 53, 2191, 10.1002/1097-0142(19840515)53:10<2191::AID-CNCR2820531031>3.0.CO;2-0
Specht, 1989, Hodgkin’s disease and age, Eur J Haematol, 43, 127, 10.1111/j.1600-0609.1989.tb00268.x
Bosi, 1989, Clinical data and therapeutic approach in elderly patients with Hodgkin’s disease, Haematologica, 74, 463
Diaz-Pavon, 1995, Outcome of Hodgkin’s disease in elderly patients, Hemat Oncol, 13, 19, 10.1002/hon.2900130104
Enblad, 1991, Treatment outcome in Hodgkin’s disease in patients above the age of 60: a population based study, Ann Oncol, 2, 297, 10.1093/oxfordjournals.annonc.a057939
Guinee, 1991, The prognosis of Hodgkin’s disease in older adults, J Clin Oncol, 9, 947, 10.1200/JCO.1991.9.6.947
Erdkamp, 1992, Hodgkin’s disease in the elderly. A registry-based analysis, Cancer, 70, 830, 10.1002/1097-0142(19920815)70:4<830::AID-CNCR2820700418>3.0.CO;2-X
Levis, 1994, Probability of cure in elderly Hodgkin’s disease patients, Haematologica, 79, 46
Forsyth, 1997, Hodgkin’s disease in patients older than 70 years of age: a registry-based analysis, Eur J Cancer, 33, 1638, 10.1016/S0959-8049(97)00119-6
Levis, 1996, Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin’s disease patients, Haematologica, 81, 450
Zinzani, 2000, Efficacy of VBM regimen in the treatment of elderly patients with Hodgkin’s disease, Haematologica, 85, 729
Hryniuk, 1987, Average relative dose intensity and the impact on design of clinical trials, Semin Oncol, 14, 65
Kaplan, 1958, Non-parametric estimation from incomplete information, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Cox, 1972, Regression models and life tables, J R Stat Soc B, 34, 187
Osterborg, 2002, Randomized, double-blind placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematological malignancies, J Clin Oncol, 20, 2486, 10.1200/JCO.2002.08.131
Monfardini, 1996, What we know on variables influencing clinical decision-making in elderly cancer patients, Eur J Cancer, 32A, 12, 10.1016/0959-8049(95)00580-3
Amsterdam Comprehensive Geriatric Oncology, 1998, Prognostic evaluation of the older cancer patients, 287
Bernabei, 2000, The comphrehensive geriatric assessment: when, where, how, Crit Rev Oncol Hematol, 33, 45, 10.1016/S1040-8428(99)00048-7
Diehl, 1998, BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective than COPP/ABVD in patients with advanced-stage Hodgkin’s lymphoma: interim report from a trial of the German Hodgkin’s Lymphoma Study Group, J Clin Oncol, 16, 3810, 10.1200/JCO.1998.16.12.3810
Carde, 2000, Is escalated BEACOPP a standard therapy for advanced Hodgkin’s disease?, Hemat J, 1, 282, 10.1038/sj.thj.6200037
Engel, 2000, Acute hematological toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin’s disease, Ann Oncol, 11, 1105, 10.1023/A:1008301225839
Sieber, 1999, Acute toxicity limits the feasibility dose and effectiveness of BEACOPP chemotherapy in advanced stage Hodgkin’s disease patients older than 65 years, Blood, 94, 2365
Weeks, 2002, Hodgkin’s disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen, J Clin Oncol, 20, 1087
Monfardini, 1995, Validation of a mutidimensional evaluation scale for use in elderly cancer patients, Cancer, 77, 395, 10.1002/(SICI)1097-0142(19960115)77:2<395::AID-CNCR24>3.0.CO;2-W
Extermann, 2000, Measuring comorbidity in older cancer patients, Eur J Cancer, 36, 453, 10.1016/S0959-8049(99)00319-6
Extermann, 1998, Comorbidity and functional status are independent in older cancer patients, J Clin Oncol, 16, 1582, 10.1200/JCO.1998.16.4.1582